Morphine sulfate attenuates hemorrhagic shock-induced hyperpermeability

Craig Charleston1, Rudolph Puana, Russell K McAllister

  • 1Department of Anesthesiology, Scott and White Clinic and Memorial Hospital, Scott, Sherwood and Brindley Foundation, Texas A&M University System Health Science Center College of Medicine,2401 South 31st St., Temple, Texas 76508, USA.

Insights

Morphine sulfate, previously thought to worsen inflammation after hemorrhagic shock, actually protects the microvasculature by reducing both increased permeability and leukocyte adherence in rats.

Area of Science:

  • Physiology
  • Pharmacology
  • Immunology

Background:

  • Morphine sulfate is used for hemorrhage control but may increase infection rates by modulating immune cells and histamine release.
  • Histamine release by morphine can increase microvascular permeability, potentially worsening inflammation after hemorrhagic shock.

Purpose of the Study:

  • To investigate the role of morphine sulfate in microvascular permeability and leukocyte adherence following hemorrhagic shock.
  • To determine if morphine sulfate aggravates or protects against inflammatory responses after hemorrhagic shock.

Main Methods:

  • Hemorrhagic shock was induced in rats by reducing mean arterial blood pressure.
  • Mesenteric postcapillary venules were examined for changes in microvascular permeability (albumin extravasation) and leukocyte adherence.
  • Morphine sulfate was administered prior to the shock period.

Main Results:

  • Hemorrhagic shock significantly increased albumin leakage and leukocyte adherence to the venular endothelium.
  • Pre-treatment with morphine sulfate (10 microg/kg) attenuated both the increased microvascular permeability and leukocyte adherence.
  • These effects were statistically significant (P < 0.05).

Conclusions:

  • Contrary to expectations, morphine sulfate did not aggravate the inflammatory response after hemorrhagic shock.
  • Morphine sulfate demonstrated a protective effect on the microvasculature by reducing hyperpermeability and leukocyte adherence.
  • These findings suggest a potential therapeutic benefit of morphine in managing inflammatory complications post-hemorrhagic shock.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...